NFKB1 and inflammatory bowel disease: Aberrant NF-κB activity has been known to be associated with many inflammatory diseases including inflammatory bowel disease [30], arthritis [31], sepsis [32], gastritis [33], asthma [34], COPD [34], and atherosclerosis [5].